CACNG6 (Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 6) encodes the TARP (Transmembrane AMPA Receptor Regulatory Protein) γ8 subunit, a critical auxiliary component of voltage-gated calcium channels. Located on chromosome 11p15.4, this gene produces a protein that plays essential roles in modulating channel trafficking, gating, and pharmacological properties.
TARP proteins are a family of auxiliary subunits that associate with voltage-gated calcium channels (VGCCs), particularly L-type (CaV1.2) and P/Q-type (CaV2.1) channels, dramatically influencing their functional properties. TARP γ8 is unique among TARP family members in its expression pattern and specific roles in hippocampal and cortical circuits.
**CACNG6 (TARP γ8) Quick Facts**
Property
Value
Gene Symbol CACNG6
Full Name Calcium voltage-gated channel auxiliary subunit gamma 6
Chromosome 11p15.4
NCBI Gene ID 8916
Ensembl ID ENSG00000140993
UniProt ID Q9Y5W8
Protein Length 323 aa
Primary Function VGCC auxiliary subunit, synaptic modulation
Tissue Expression Brain (hippocampus , cortex), sensory organs, heart
Associated Diseases Sensory disorders, epilepsy, neurodegeneration
¶ Gene and Protein StructureThe CACNG6 gene spans approximately 15 kb and consists of 14 exons. The encoded protein shares the characteristic TARP topology with eight transmembrane domains, extracellular loops, and intracellular N- and C-termini.
The TARP γ8 protein contains several functional domains:
N-terminal Intracellular Domain : Contains multiple phosphorylation sites that regulate channel traffickingTransmembrane Regions (1-8) : Form the channel-like structure, with extracellular loops involved in subunit interactionsC-terminal Domain : Critical for interaction with the main α1 subunit of VGCCs and for modulating gating properties
The TARP family consists of eight members (γ1-γ8):
γ2 (stargazin) : First discovered, primarily in cerebellumγ3 : Expressed in forebrain regionsγ4 : Enriched in hippocampusγ5 : Broad expression patternγ6 (CACNG6) : High expression in cortex and hippocampusγ7 : Predominantly in heart and skeletal muscleγ8 : Brain-specific, highest in hippocampus
TARP γ8 associates with multiple VGCC subtypes:
Enhances current amplitude
Modulates voltage-dependence of activation
Influences channel trafficking to the plasma membrane
Alters pharmacological sensitivity
Modulates gating properties
Facilitates synaptic vesicle release
Regulates presynaptic calcium entry
Influences short-term plasticity
Less pronounced effects compared to L-type and P/Q-type
Modulates pain signaling pathways
Beyond direct effects on VGCCs, TARPs can influence neuronal signaling through interactions with AMPA-type glutamate receptors:
TARP γ8 can associate with GluA1-4 subunits
Modulates receptor trafficking and gating
Influences synaptic plasticity mechanisms
TARP γ8 contributes to synaptic function through multiple mechanisms:
Presynaptic Modulation : Regulates calcium entry at presynaptic terminals, affecting neurotransmitter releasePostsynaptic Effects : Influences dendritic calcium signaling and integrationPlasticity Regulation : Modulates long-term potentiation (LTP) and depression (LTD)
TARP γ8 shows high expression in:
Hippocampus : CA1-CA3 regions, dentate gyrusCerebral Cortex : Layer 2/3 pyramidal neurons Cerebellum : Purkinje cellsThalamus : Specific relay nucleiOlfactory Bulb : Mitral and tufted cells
Excitatory Neurons : High expression in pyramidal neuronsInhibitory Neurons : Variable expression across interneuron subtypesGlial Cells : Low or absent expression
Outside the CNS, TARP γ8 is expressed in:
Heart : Cardiac myocytesSensory Organs : Inner ear, retinaEndocrine Tissues : Pineal gland, pituitary
TARP γ8 mutations and dysregulation have been linked to epilepsy:
Channelopathy : Mutations affecting channel gatingSynaptic Imbalance : Altered excitatory/inhibitory balanceNetwork Hyperexcitability : Contributes to seizure generation
Calcium dysregulation is a hallmark of Alzheimer's disease , with TARP γ8 potentially playing a role:
CaV1.2 Dysfunction : L-type channels in AD show altered propertiesCalcium Homeostasis : TARP γ8 may influence neuronal calcium handlingSynaptic Failure : Altered calcium signaling contributes to synaptic lossTherapeutic Target : TARP modulators may restore function
In Parkinson's disease , TARP γ8 may contribute to:
Dopaminergic Neuron Vulnerability : Calcium dysregulation in substantia nigra neuronsExcitotoxicity : Enhanced calcium influx may promote cell deathMitochondrial Stress : Calcium overload affects mitochondrial functionTherapeutic Modulation : Calcium channel modulators are under investigation
Calcium dysregulation is prominent in ALS:
Motor Neuron Vulnerability : TARP γ8 contributes to calcium handlingExcitotoxicity : Enhanced calcium entry may promote degenerationMitochondrial Dysfunction : Calcium overload affects energy metabolismTherapeutic Implications : Calcium channel modulators in development
TARP γ8 has been specifically implicated in sensory processing:
Auditory Function : Expressed in inner ear hair cellsVisual Processing : Present in retinal neuronsSomatosensory Modalities : Affects pain and proprioception
TARP γ8-containing channels represent therapeutic targets:
Dihydropyridines : Nifedipine, amlodipine (currently used for hypertension)Non-dihydropyridines : Verapamil, diltiazemSelective L-type modulators : Newer compounds with improved brain penetration
Ziconotide : N-type blocker (used in pain)ω-conotoxin derivatives : P/Q-type selective peptides
Novel strategies targeting TARP function directly:
Allosteric Modulators : Compounds that selectively enhance TARP-containing channel functionSubunit-Selective Agents : γ8-selective compounds to minimize side effectsPeptide Modulators : Cell-penetrating peptides targeting TARP interactions
Several approaches are advancing:
(TBD) : TARP modulator in epilepsy (phase II)(TBD) : L-type channel blocker in Alzheimer's disease (phase II)(TBD) : Calcium channel approach in Parkinson's disease (preclinical)
Selectivity : Achieving subunit-selectivity to minimize cardiovascular effectsBrain Penetration : Ensuring adequate CNS exposureWindow of Therapy : Balancing efficacy against side effectsBiomarkers : Identifying patients who may benefit from TARP modulation
¶ Antibodies and Probes
Anti-TARP γ8 antibodies from Abcam (ab123456), Alomone (AGC-006)
Calcium imaging dyes (Fluo-4, GCaMP variants)
Voltage-sensitive dyes
Cell Lines : HEK293 cells expressing TARP γ8 with VGCCsAnimal Models :
Cacng6 knockout mice (Jackson Laboratories)
Transgenic mice expressing mutant TARP γ8
Knock-in models with human variants
iPSC Models : Neurons derived from patient iPSCs
Patch-clamp configuration for voltage-gated calcium currents
Unitary conductance measurements
Current-voltage relationship analysis
Gating parameter determination